Vaxart, Inc.

VXRT · OTC · SIC 2836: Biological Products, (No Diagnostic Substances)
397
SEC Filings

Business Summary

Vaxart, Inc. is a clinical-stage biotechnology company focused on developing oral recombinant vaccines using its proprietary VAAST platform. The company's tablet vaccines use a non-replicating Ad5 vector to deliver antigens and adjuvants to the small intestine, targeting mucosal and systemic immunity. Pipeline candidates address norovirus, COVID-19, influenza, and HPV-related cervical cancer. No products are currently approved or marketed.

Next Earnings

Q2 FY2026 — expected 2026-09-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVXRTdiscussed_in_filing Artificial Intelligence
topic_mentionVXRTdiscussed_in_filing Cybersecurity
topic_mentionVXRTdiscussed_in_filing Trusted Computing
topic_mentionVXRTdiscussed_in_filing Blockchain & Crypto
topic_mentionVXRTdiscussed_in_filing Regulation
topic_mentionVXRTdiscussed_in_filing Healthcare & Bio
topic_mentionVXRTdiscussed_in_filing Platform & Ecosystem
topic_mentionVXRTdiscussed_in_filing Sovereign & Government
topic_mentionVXRTdiscussed_in_filing Artificial Intelligence
topic_mentionVXRTdiscussed_in_filing Cybersecurity
topic_mentionVXRTdiscussed_in_filing Trusted Computing
topic_mentionVXRTdiscussed_in_filing Blockchain & Crypto
topic_mentionVXRTdiscussed_in_filing Regulation
topic_mentionVXRTdiscussed_in_filing Healthcare & Bio
topic_mentionVXRTdiscussed_in_filing Platform & Ecosystem
topic_mentionVXRTdiscussed_in_filing Sovereign & Government
topic_mentionVXRTdiscussed_in_filing Artificial Intelligence
topic_mentionVXRTdiscussed_in_filing Cybersecurity
topic_mentionVXRTdiscussed_in_filing Trusted Computing
topic_mentionVXRTdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-132025-12-310001437749-26-008023EDGAR93K words
2025-03-202024-12-310001437749-25-008572EDGAR—
2024-03-142023-12-310001437749-24-007865EDGAR—
2023-03-152022-12-310001437749-23-006688EDGAR—
2022-02-242021-12-310001437749-22-004354EDGAR—
2021-02-252020-12-310001437749-21-004115EDGAR—
2020-03-192019-12-310001437749-20-005683EDGAR—
2019-02-062018-12-310001513162-19-000041EDGAR—
2017-09-012017-06-300001437749-17-015526EDGAR—
2016-09-132016-06-300001437749-16-038645EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001437749-25-034840EDGAR34K words
2025-08-132025-06-300001437749-25-026514EDGAR—
2025-05-132025-03-310001437749-25-016459EDGAR—
2024-11-132024-09-300001437749-24-034927EDGAR—
2024-08-082024-06-300001437749-24-025556EDGAR—
2024-05-132024-03-310001437749-24-016236EDGAR—
2023-11-022023-09-300001437749-23-030009EDGAR—
2023-08-032023-06-300001437749-23-021966EDGAR—
2023-05-042023-03-310001437749-23-012560EDGAR—
2022-11-092022-09-300001437749-22-026427EDGAR—
2022-08-082022-06-300001437749-22-019415EDGAR—
2022-05-092022-03-310001437749-22-011554EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-120001437749-26-007968EDGAR3K words
2025-12-290001437749-25-038774EDGAR—
2025-11-130001437749-25-034829EDGAR—
2025-11-050001437749-25-033362EDGAR—
2025-10-100001437749-25-030868EDGAR—
2025-09-190001437749-25-029485EDGAR—
2025-09-190001437749-25-029434EDGAR—
2025-09-080001437749-25-028570EDGAR—
2025-09-020001437749-25-028167EDGAR—
2025-08-290001437749-25-028047EDGAR—

397 total filings indexed. 365 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Tags

infectious-disease-vaccines norovirus-prevention covid-19-prevention influenza-prevention hpv-related-cancer-therapeutics mucosal-vaccine-delivery non-replicating-adenovirus-type-5-(ad5)-vector toll-like-receptor-3-(tlr3)-agonist-dsrna-adjuvant enteric-coated-tablet-delivery

Company Identity

CIK0000072444
TickerVXRT
ExchangeOTC
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9eb82121e7d978d7964aec8348d966048cf042180e7f95b359e5a321a469fc2b
parent: e2636cdd929b377f45828b9e3388c2bb767ae9615ff6ee69a23da619f8f4be11
content hash: 7d06a6894459f44e01a1223ce3d16d7a9721655db448a27b3b85da205a73cd61
signed: 2026-04-13T04:48:10.024Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf